THOMAS MEECE: Open Payments
NPI 1568924728 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 20 payments from 11 companies in 2025. Trend: 2023 $704 · 2024 $606 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| UROGEN PHARMA, INC. | 3 | $70 |
| COLOPLAST CORP | 2 | $52 |
| Endo USA, Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $27 |
| Teleflex LLC | 1 | $25 |
| TOLMAR, INC. | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $20 |
Products named: PLUVICTO, AVEED, Nubeqa, ADSTILADRIN, BOTOX, BARRIGEL, JATENZO, PROVENGE.
Industry payments across MS — which companies pay providers there.
